CAARI 2004: 18th Int'l Conf of Accelerators in Research

描述(由申请人提供)：本提案是为了获得资金以支持第18届加速器在研究和工业中的应用会议(CAARI 2004)的一部分。这次会议将加速器科学家、医学研究人员和加速器制造商聚集在一个大团体中。整个会议将由来自大约50个国家的800多名与会者组成。医学研讨会将举行为期四天的会议。它将由八场会议和45多名发言者组成。我们预计将有150多名医学和加速器科学家和制造商参加研讨会。 大多数会议的主要目的是讨论医用放射性同位素的加速器生产及其在许多诊断和放射治疗应用中的用途。大多数主要的加速器和设备制造商也出席了这些会议。这是世界上唯一一次将医学诊断专家、放射治疗专家、核物理学家、加速器和零部件制造工程师聚集在一起的会议。这些群体之间的相互作用是会议的一个主要目标。会议的重点是总结最先进的诊断和放射治疗方法和技术，并在这些小组之间建立亟需的对话。在2004年的会议上，我们已经或将就以下问题征集演讲者：新的回旋加速器发展、靶材制造和加工、放射性药物开发和标记程序、从F-18到I-124、In-111、Ti-201、Ga-67的加速器生产以及用于放射诊断和放射治疗以及直接粒子束治疗的其他同位素。我们也感谢NCI的工作人员就其他重点领域提出建议。

DESCRIPTION (provided by applicant): This proposal is being written to obtain funds to help support a Medical Symposium that is part of the 18th Conference on the Application of Accelerators in Research and Industry (CAARI 2004). The conference brings together accelerator scientists, medical researchers, and accelerator manufactures in one large group. The whole conference will be composed of over 800 participants from approximately 50 countries. The Medical Symposium will run four days of the conference. It will be composed of eight sessions and over 45 speakers. We anticipate over 150 medical and accelerator scientists and manufactures will attend the symposium. The main objective of most of the sessions is to discuss the accelerator production of medical radioisotopes and their use in the many diagnostic and radiation therapy applications. Most of the major accelerator and equipment manufactures are also present at these meetings. It is the only conference in the world that brings together medical diagnosticians, radiation therapists, nuclear physicist and accelerator and component manufacturing engineers. The interplay between these groups is a major goal of the conference. The focus of the meeting is to summarize the "state of the art" diagnostic and radiation therapeutic methods and technique and to establish the much needed dialogue between these groups. For the 2004 conference we have already, or will enlist speakers on the following: new cyclotron developments, target fabrication and processing, radiopharmaceutical development and tagging procedures, accelerator production of isotopes ranging from F-18 to I-124, In-111, TI-201, Ga-67 and others for radiodiagnostics and radiotherapeutics and direct particle beam therapy. We would also appreciate suggestions from the staff at NCI in regard to other focused areas.